SecBot SecBot

BBTX

Bambusa Therapeutics, Inc.
Nasdaq· CIK 0002044950 Biotech & Drug Discovery
$16.00 +0.00 (+0.00%)
Nov 3 4:00 PM ET · prev $16.00
Market cap
$767.0M
Small cap
Insider net
+$12.0M
12 mo · excl. 4 subscriber-only trades
Filing reports
4
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 3 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/4

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersMIXED

    2 insiders bought $12.0M. No open-market sales. Excludes 4 subscriber-only trades.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 3, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 3, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 2, 2026 SEC
Bambusa Therapeutics filed an amended and restated certificate of incorporation and adopted amended and restated…
8-K · Impact 2/10
Nov 2, 2026 Insider
Xu Shanshan disposed of 4,155 shares
See remarks
Nov 2, 2026 Insider
Salvia Investment GmbH disposed of 3,135,066 shares
10%+ Owner
Nov 2, 2026 Insider
Xu Shanshan acquired 16,358 shares
See remarks
Oct 30, 2026 Listing status
New Listing: BBTX · Bambusa Therapeutics, Inc. - Common stock
Listed on exchange Q
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Insider ledger

Form 4
$12.0M
bought · 2 insiders
$0
sold · 0 insiders · excl. 4 subscriber-only trades
DateInsiderTypeValue
Nov 2, 2026
Xu Shanshan
See remarks
Nov 2, 2026
CONVERT4,155 sh
Nov 2, 2026
Salvia Investment GmbH
10%+ Owner
Nov 2, 2026
CONVERT3,135,066 sh
Nov 2, 2026
Xu Shanshan
See remarks
Nov 2, 2026
CONVERT16,358 sh
Nov 2, 2026
Xu Shanshan
See remarks
Nov 2, 2026
CONVERT94,050 sh
Nov 2, 2026
Xu Shanshan
See remarks
Nov 2, 2026
CONVERT15,789 sh
Nov 2, 2026
Jeggle Helmut Wolfgang
Director
Nov 2, 2026
BUY$6.0M
Nov 2, 2026
Jeggle Helmut Wolfgang
Director
Nov 2, 2026
CONVERT1,473,775 sh
Nov 2, 2026
Xu Shanshan
See remarks
Nov 2, 2026
CONVERT147,238 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

SecBot reports

4 filings · 3 bullish · 0 bearish · 1 neutral
All BBTX filing & press-release reports (4)